Anita Deswal, MD, MPH, MBBS

Peer-Reviewed Articles

1. Palaskas N, Lopez-Mattei J, Durand JB, Iliescu C, Deswal A. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc 9(2):e013757, 2020. e-Pub 2020. PMID: 31960755.
2. Walther CP, Winkelmayer WC, Niu J, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis 74(5):650-658, 2019. e-Pub 2019. PMID: 31160142.
3. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, PiÑa IL, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Heart Failure Society of America. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America. J Card Fail 25(8):584-619, 2019. e-Pub 2019. PMID: 31174952.
4. Dunlay SM, Givertz MM, Aguilar D, Allen LA, Chan M, Desai AS, Deswal A, Dickson VV, Kosiborod MN, Lekavich CL, McCoy RG, Mentz RJ, Piña IL, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update. Circulation 140(7):e294-e324, 2019. e-Pub 2019. PMID: 31167558.
5. Trang A, Kampangkaew J, Fernandes R, Tiwana J, Misra A, Hamzeh I, Blaustein A, Aguilar D, Shah T, Ballantyne C, Quinones M, Nagueh SF, Dokanish H, Virani SS, Deswal A, Kirkpatrick JN, Nambi V. Understanding by General Providers of the Echocardiogram Report. Am J Cardiol 124(2):296-302, 2019. e-Pub 2019. PMID: 31104774.
6. House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA, Conference Participants. Heart Failure in Chronic Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 95(6):1304-1317, 2019. e-Pub 2019. PMID: 31053387.
7. Vest AR, Chan M, Deswal A, Givertz MM, Lekavich C, Lennie T, Litwin SE, Parsly L, Rodgers JE, Rich MW, Schulze PC, Slader A, Desai A. Nutrition, Obesity, and Cachexia in Patients With Heart Failure: A Consensus Statement from the Heart Failure Society of America Scientific Statements Committee. J Card Fail 25(5):380-400, 2019. e-Pub 2019. PMID: 30877038.
8. Levine GN, O'Gara PT, Beckman JA, Al-Khatib SM, Birtcher KK, Cigarroa JE, de Las Fuentes L, Deswal A, Fleisher LA, Gentile F, Goldberger ZD, Hlatky MA, Joglar JA, Piano MR, Wijeysundera DN. Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139(17):e879-e886, 2019. PMID: 30892927.
9. Levine GN, O'Gara PT, Beckman JA, Al-Khatib SM, Birtcher KK, Cigarroa JE, de Las Fuentes L, Deswal A, Fleisher LA, Gentile F, Goldberger ZD, Hlatky MA, Joglar JA, Piano MR, Wijeysundera DN. Recent Innovations, Modifications, and Evolution of ACC/AHA Clinical Practice Guidelines: An Update for Our Constituencies: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 73(15):1990-1998, 2019. e-Pub 2019. PMID: 30904245.
10. Hira RS, Kataruka A, Akeroyd JM, Ramsey DJ, Pokharel Y, Gurm HS, Nasir K, Deswal A, Jneid H, Alam M, Ballantyne CM, Petersen LA, Virani SS. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes 12(1):e004817, 2019. PMID: 30636483.
11. Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis 72(4):620-622, 2018. e-Pub 2018. PMID: 29784611.
12. Lenihan CR, Liu S, Deswal A, Montez-Rath ME, Winkelmayer WC. De Novo Heart Failure after Kidney Transplantation: Trends in Incidence and Outcomes. Am J Kidney Dis 72(2):223-233, 2018. e-Pub 2018. PMID: 29605378.
13. Misra A, Deswal A. NT-proBNP-guided and conventional therapies did not differ for readmission or mortality in acute decompensated HF. Ann Intern Med 169(4):JC21, 2018. PMID: 30128511.
14. Faza NN, Akeroyd JM, Ramsey DJ, Shah T, Nasir K, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA 31(7):39-45, 2018. PMID: 29957606.
15. Walther CP, Niu J, Winkelmayer WC, Cheema FH, Nair AP, Morgan JA, Fedson SE, Deswal A, Navaneethan SD. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc 7(14), 2018. e-Pub 2018. PMID: 29980520.
16. Virani SS, Akeroyd JM, Ramsey DJ, Deswal A, Nasir K, Rajan SS, Ballantyne CM, Petersen LA. Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag 21(3):209-216, 2018. e-Pub 2017. PMID: 28994631.
17. Saeed A, Nambi V, Sun W, Virani SS, Taffet GE, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM. Short-Term Global Cardiovascular Disease Risk Prediction in Older Adults. J Am Coll Cardiol 71(22):2527-2536, 2018. e-Pub 2018. PMID: 29535064.
18. Basra SS, Wang TY, Simon DN, Chiswell K, Virani SS, Alam M, Nambi V, Denktas AE, Deswal A, Bozkurt B, Ballantyne CM, Peterson ED, Jneid H. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc 7(12), 2018. e-Pub 2018. PMID: 29886424.
19. Nambi V, Deswal A, Ballantyne CM. Prevention of "Failure": Is It a Failure of Prevention?. Circulation 137(2):106-108, 2018. PMID: 29311345.
20. Khalid U, Deswal A. Observation Versus Inpatient Stay for Heart Failure: Is it Semantics?. J Am Heart Assoc 7(3), 2018. e-Pub 2018. PMID: 29386208.
21. Saeed A, Nambi V, Sun W, Virani SS, Taffet G, Deswal A, Selvin E, Matsushita K, Wagenknecht LE, Hoogeveen R, Coresh J, de Lemos JA, Ballantyne CM. Do Biomarkers Improve Short-term Risk Prediction of Global Cardiovascular Events in Older Adults? Insights from the Atherosclerosis Risk in Communities Study. Journal of Clinical Lipidology 12:525-526, 2018.
22. Nguyen P, Kamran H, Nasir S, Chan W, Shah T, Deswal A, Bozkurt B. Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine. Am J Cardiol 119(12):2030-2034, 2017. e-Pub 2017. PMID: 28456314.
23. Khalid U, Wruck LM, Quibrera PM, Bozkurt B, Nambi V, Virani SS, Jneid H, Agarwal S, Chang PP, Loehr L, Basra SS, Rosamond W, Ballantyne CM, Deswal A. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol 233:61-66, 2017. e-Pub 2017. PMID: 28185703.
24. Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele CE, Solomon SD, Bozkurt B, Selvin E, Ballantyne CM, Deswal A. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail 5(1):56-63, 2017. e-Pub 2016. PMID: 28017350.
25. Bozkurt B, Aguilar D, Deswal A, Dunbar SB, Francis GS, Horwich T, Jessup M, Kosiborod M, Pritchett AM, Ramasubbu K, Rosendorff C, Yancy C, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; and Council on Quality and Outcomes Research. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association. Circulation 134(23):e535-e578, 2016. e-Pub 2016. PMID: 27799274.
26. Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E, Vasan RS, Ramasubbu K, Rasmusson K, Towbin JA, Yancy C, American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement from the American Heart Association. Circulation 134(23):e579-e646, 2016. e-Pub 2016. PMID: 27832612.
27. Hira RS, Cowart JB, Akeroyd JM, Ramsey DJ, Pokharel Y, Nambi V, Jneid H, Deswal A, Denktas A, Taylor A, Nasir K, Ballantyne CM, Petersen LA, Virani SS. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol 118(8):1144-1149, 2016. e-Pub 2016. PMID: 27553104.
28. Wan SH, Stevens SR, Borlaug BA, Anstrom KJ, Deswal A, Felker GM, Givertz MM, Bart BA, Tang WH, Redfield MM, Chen HH. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure with Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circ Heart Fail 9(8), 2016. PMID: 27512103.
29. Shah T, Deswal A. ACP Journal Club. Review: In HF with reduced EF, nurse-led titration of HF drugs reduces hospitalizations and mortality. Ann Intern Med 164(8):JC41, 2016. PMID: 27089090.
30. Pokharel Y, Wei J, Hira RS, Kalra A, Shore S, Kerkar PG, Kumar G, Risch S, Vicera V, Oetgen WJ, Deswal A, Turakhia MP, Glusenkamp N, Virani SS. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol 39(3):145-9, 2016. e-Pub 2016. PMID: 26880649.
31. Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 133(7):631-8, 2016. e-Pub 2016. PMID: 26746175.
32. Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E. NT-proBNP and Heart Failure Risk among Individuals With and Without Obesity: The ARIC Study. Circulation 133(7):631-8, 2016.
33. Shah AM, Claggett B, Sweitzer NK, Shah SJ, Deswal A, Anand IS, Fleg JL, Pitt B, Pfeffer MA, Solomon SD. Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circ Heart Fail 8(6):1052-8, 2015. e-Pub 2015. PMID: 26475142.
34. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch SA, Oetgen WJ, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights from the NCDR PINNACLE Registry. J Am Coll Cardiol 66(16):1803-1812, 2015. PMID: 26483105.
35. Borlaug BA, Chen H, Lin G, Redfield MM, Lewis GD, Semigran MJ, McNulty SE, LeWinter M, Deswal A, Margulies KB. Response to Letter Regarding Article, “Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction”. Circ Heart Fail 8(4):840, 2015. PMID: 26405727.
36. Borlaug BA, Lewis GD, McNulty SE, Semigran MJ, LeWinter M, Chen H, Lin G, Deswal A, Margulies KB, Redfield MM. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction. Circ Heart Fail 8(3):533-41, 2015. e-Pub 2015. PMID: 25782985.
37. Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, Margulies KB, Cappola TP, Konstam MA, Semigran MJ, McNulty SE, Lee KL, Shah MR, Hernandez AF, NHLBI Heart Failure Clinical Research Network. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation 131(20):1763-71, 2015. e-Pub 2015. PMID: 25986447.
38. Gonçalves A, Claggett B, Jhund PS, Rosamond W, Deswal A, Aguilar D, Shah AM, Cheng S, Solomon SD. Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study. Eur Heart J 36(15):939-45, 2015. e-Pub 2015. PMID: 25602025.
39. Bandeali SJ, Gosch K, Alam M, Kayani WT, Jneid H, Fiocchi F, Wilson JM, Chan PS, Deswal A, Maddox TM, Virani SS. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol 115(8):1013-8, 2015. e-Pub 2015. PMID: 25721483.
40. Albert NM, Barnason S, Deswal A, Hernandez A, Kociol R, Lee E, Paul S, Ryan CJ, White-Williams C, American Heart Association Complex Cardiovascular Patient and Family Care Committee of the Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Transitions of Care in Heart Failure: A Scientific Statement from the American Heart Association. Circ Heart Fail 8(2):384-409, 2015. e-Pub 2015. PMID: 25604605.
41. Virani SS, Woodard LD, Ramsey DJ, Urech TH, Akeroyd JM, Shah T, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol 115(1):21-6, 2015. e-Pub 2014. PMID: 25456865.
42. Abraham NS, Naik AD, Street RL, Castillo DL, Deswal A, Richardson PA, Hartman CM, Shelton G, Fraenkel L. Complex antithrombotic therapy: determinants of patient preference and impact on medication adherence. Patient Prefer Adherence 9:1657-68, 2015. e-Pub 2015. PMID: 26640372.
43. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol 65(2):111-21, 2015. PMID: 25593051.
44. Basra SS, Pokharel Y, Hira RS, Bandeali SJ, Nambi V, Deswal A, Nasir K, Martin SS, Vogel RA, Roberts AJ, Ballantyne CM, Virani SS. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol 114(12):1836-40, 2014. e-Pub 2014. PMID: 25432152.
45. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamond WD, Chang PP, Coresh J, Virani SS, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol 64(25):2743-9, 2014. PMID: 25541126.
46. Kurrelmeyer KM, Ashton Y, Xu J, Nagueh SF, Torre-Amione G, Deswal A. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail 20(8):560-8, 2014. e-Pub 2014. PMID: 24905296.
47. Safdar Z, Tamez E, Chan W, Arya B, Ge Y, Deswal A, Bozkurt B, Frost A, Entman M. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail 2(4):412-21, 2014. e-Pub 2014. PMID: 25023820.
48. Deswal A, Tamang BK, Bala A. Study of aortic- common iliac bifurcation and its clinical significance. J Clin Diagn Res 8(7):AC06-8, 2014. e-Pub 2014. PMID: 25177553.
49. Bavishi C, Ather S, Bambhroliya A, Jneid H, Virani SS, Bozkurt B, Deswal A. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol 113(11):1834-8, 2014. e-Pub 2014. PMID: 24837261.
50. Rogers PA, Daye J, Huang H, Blaustein A, Virani S, Alam M, Kumar A, Paniagua D, Kar B, Bozkurt B, Ballantyne CM, Deswal A, Jneid H. Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Int J Cardiol 172(1):239-41, 2014. e-Pub 2014. PMID: 24462137.
51. Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail 7(1):123-30, 2014. e-Pub 2013. PMID: 24162898.
52. Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, Boerwinkle E, Hoogeveen RC, Aguilar D, Astor BC, Srinivas PR, Deswal A, Mosley TH, Coresh J, Folsom AR, Heiss G, Ballantyne CM. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem 59(12):1802-10, 2013. e-Pub 2013. PMID: 24036936.
53. Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM, NHLBI Heart Failure Clinical Research Network. Low-dose Dopamine or low-dose Nesiritide in Acute Heart Failure with Renal Dysfunction: the ROSE Acute Heart Failure Randomized Trial. JAMA 310(23):2533-43, 2013. PMID: 24247300.
54. Bandeali SJ, Kayani WT, Lee VV, Elayda M, Alam M, Huang HD, Wilson JM, Jneid H, Birnbaum Y, Deswal A, Farmer J, Ballantyne CM, Virani SS. Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther 31(5):291-7, 2013. PMID: 23517524.
55. Huang HD, Alam M, Hamzeh I, Virani S, Deswal A, Aguilar D, Rogers P, Kougias P, Birnbaum Y, Paniagua D, Kar B, Ballantyne C, Bozkurt B, Jneid H. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol 168(4):3741-6, 2013. e-Pub 2013. PMID: 23845772.
56. Ather S, Bavishi C, McCauley MD, Dhaliwal A, Deswal A, Johnson S, Chan W, Aguilar D, Pritchett AM, Ramasubbu K, Wehrens XH, Bozkurt B. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol 167(5):1912-7, 2013. e-Pub 2012. PMID: 22633437.
57. Ather S, Hira RS, Shenoy M, Fatemi O, Deswal A, Aguilar D, Ramasubbu K, Bolos M, Chan W, Bozkurt B. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol 166(2):394-8, 2013. e-Pub 2011. PMID: 22119115.
58. Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E, RELAX Trial. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309(12):1268-77, 2013. PMID: 23478662.
59. Khalid U, Deswal A. ACP Journal Club. Review: in systolic heart failure, low-sodium diets increase mortality compared with normal-sodium diets. Ann Intern Med 158(4):JC7, 2013. PMID: 23420258.
60. Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E, Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367(24):2296-304, 2012. e-Pub 2012. PMID: 23131078.
61. Bishu K, Deswal A, Chen HH, LeWinter MM, Lewis GD, Semigran MJ, Borlaug BA, McNulty S, Hernandez AF, Braunwald E, Redfield MM. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J 164(5):763-770.e3, 2012. e-Pub 2012. PMID: 23137508.
62. Ramasubbu K, Deswal A, Chan W, Aguilar D, Bozkurt B. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail 18(10):792-8, 2012. PMID: 23040115.
63. Redfield MM, Borlaug BA, Lewis GD, Mohammed SF, Semigran MJ, Lewinter MM, Deswal A, Hernandez AF, Lee KL, Braunwald E, Heart Failure Clinical Research Network. PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. Circ Heart Fail 5(5):653-9, 2012. PMID: 22991405.
64. Desai RJ, Ashton CM, Deswal A, Morgan RO, Mehta HB, Chen H, Aparasu RR, Johnson ML. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf 21(3):233-40, 2012. e-Pub 2011. PMID: 21786364.
65. Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, Deswal A, Heiss G, Chambless LE. Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail 5(2):152-9, 2012. e-Pub 2012. PMID: 22271752.
66. Bart BA, Goldsmith SR, Lee KL, Redfield MM, Felker GM, O'Connor CM, Chen HH, Rouleau JL, Givertz MM, Semigran MJ, Mann D, Deswal A, Bull DA, Lewinter MM, Braunwald E. Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail 18(3):176-82, 2012. e-Pub 2012. PMID: 22385937.
67. Bozkurt B, Bolos M, Deswal A, Ather S, Chan W, Mann DL, Carabello B. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail 18(3):183-93, 2012. e-Pub 2011. PMID: 22385938.
68. Pritchett AM, Deswal A, Aguilar D, Foreyt JP, Chan W, Mann DL, Ballantyne C, Bozkurt B. Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study. J Obes Weight Loss Ther 2(2):1-8, 2012. e-Pub 2012. PMID: 23125955.
69. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XH, Deswal A. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59(11):998-1005, 2012. PMID: 22402071.
70. Deswal A. Obesity, leptin, and incident heart failure. J Am Coll Cardiol 58(18):1878-80, 2011. PMID: 22018298.
71. Deswal A, Richardson P, Bozkurt B, Mann DL. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail 17(8):634-42, 2011. e-Pub 2011. PMID: 21807324.
72. Ather S, Peterson LE, Divakaran VG, Deswal A, Ramasubbu K, Giorgberidze I, Blaustein A, Wehrens XH, Mann DL, Bozkurt B. Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol 150(3):264-9, 2011. e-Pub 2010. PMID: 20471706.
73. Subramanian D, Subramanian V, Deswal A, Mann DL. New predictive models of heart failure mortality using time-series measurements and ensemble models. Circ Heart Fail 4(4):456-62, 2011. e-Pub 2011. PMID: 21562057.
74. Ather S, Chan W, Chillar A, Aguilar D, Pritchett AM, Ramasubbu K, Wehrens XH, Deswal A, Bozkurt B. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J 161(3):567-73, 2011. PMID: 21392613.
75. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O'Connor CM, NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797-805, 2011. PMID: 21366472.
76. Aguilar D, Chan W, Bozkurt B, Ramasubbu K, Deswal A. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail 4(1):53-8, 2011. e-Pub 2010. PMID: 20952583.
77. Loehr LR, Rosamond WD, Poole C, McNeill AM, Chang PP, Deswal A, Folsom AR, Heiss G. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol 172(7):781-9, 2010. e-Pub 2010. PMID: 20716703.
78. Ramasubbu K, Deswal A, Herdejurgen C, Aguilar D, Frost AE. A prospective echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med 3:279-86, 2010. e-Pub 2010. PMID: 21042428.
79. Anand IS, Deswal A, Kereiakes DJ, Purkayastha D, Zappe DH. Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure. Vasc Health Risk Manag 6:449-55, 2010. e-Pub 2010. PMID: 20730060.
80. Cully JA, Phillips LL, Kunik ME, Stanley MA, Deswal A. Predicting quality of life in veterans with heart failure: the role of disease severity, depression, and comorbid anxiety. Behav Med 36(2):70-6, 2010. PMID: 20497945.
81. Gordon HS, Nowlin PR, Maynard D, Berbaum ML, Deswal A. Mortality after hospitalization for heart failure in blacks compared to whites. Am J Cardiol 105(5):694-700, 2010. PMID: 20185019.
82. Aguilar D, Deswal A, Ramasubbu K, Mann DL, Bozkurt B. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol 105(3):373-7, 2010. e-Pub 2009. PMID: 20102951.
83. Cully JA, Stanley MA, Deswal A, Hanania NA, Phillips LL, Kunik ME. Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry 12(4), 2010. PMID: 21085552.
84. Cully JA, Johnson M, Moffett ML, Khan M, Deswal A. Depression and anxiety in ambulatory patients with heart failure. Psychosomatics 50(6):592-8, 2009. PMID: 19996230.
85. Dhaliwal AS, Habib G, Deswal A, Verduzco M, Souchek J, Ramasubbu K, Aguilar D, Ma TS, Jneid HM, Bolos M, Bozkurt B. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol 104(2):270-5, 2009. PMID: 19576359.
86. Aguilar D, Bozkurt B, Ramasubbu K, Deswal A. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol 54(5):422-8, 2009. PMID: 19628117.
87. Dhaliwal AS, Deswal A, Pritchett A, Aguilar D, Kar B, Souchek J, Bozkurt B. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail 15(4):293-9, 2009. e-Pub 2008. PMID: 19398076.
88. Cully JA, Jimenez DE, Ledoux TA, Deswal A. Recognition and treatment of depression and anxiety symptoms in heart failure. Prim Care Companion J Clin Psychiatry 11(3):103-9, 2009. PMID: 19617942.
89. Dhaliwal AS, Chu D, Deswal A, Bozkurt B, Coselli JS, LeMaire SA, Huh J, Bakaeen FG. The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes. Am J Surg 196(5):720-5, 2008. e-Pub 2008. PMID: 18789415.
90. Hassan SA, Deswal A, Bozkurt B, Aguilar D, Mann DL, Pritchett AM. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail 14(7):590-5, 2008. e-Pub 2008. PMID: 18722325.
91. Ahmed A, Aboshady I, Munir SM, Gondi S, Brewer A, Gertz SD, Lai D, Shaik NA, Shankar KJ, Deswal A, Casscells SW. Decreasing body temperature predicts early rehospitalization in congestive heart failure. J Card Fail 14(6):489-96, 2008. e-Pub 2008. PMID: 18672197.
92. Das A, Abraham S, Deswal A. Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol 23(3):233-40, 2008. PMID: 18382212.
93. Kazi D, Deswal A. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Cardiol Clin 26(1):1-14, v, 2008. PMID: 18312901.
94. Ramasubbu K, Estep J, White DL, Deswal A, Mann DL. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 51(4):415-26, 2008. PMID: 18222351.
95. Aguilar D, Bozkurt B, Pritchett A, Petersen NJ, Deswal A. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol 50(1):32-6, 2007. e-Pub 2007. PMID: 17601542.
96. Patel P, White DL, Deswal A. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up. Am Heart J 153(4):515-22, 2007. PMID: 17383287.
97. Abraham NS, El-Serag HB, Hartman C, Richardson P, Deswal A. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther 25(8):913-24, 2007. PMID: 17402995.
98. Deswal A, Petersen NJ, Urbauer DL, Wright SM, Beyth R. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J 152(2):348-54, 2006. PMID: 16875921.
99. Deswal A, Bozkurt B. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol 97(8):1228-31, 2006. e-Pub 2006. PMID: 16616031.
100. Bozkurt B, Deswal A. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 150(6):1233-9, 2005. PMID: 16338264.
101. Deswal A, Mann DL. Can valsartan reduce the occurrence of atrial fibrillation in heart failure patients?. Nat Clin Pract Cardiovasc Med 2(10):502-3, 2005. PMID: 16186843.
102. Soltero ER, Petersen NJ, Earle NR, Glaeser DH, Urbauer DL, Deswal A. Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and non-cardiac vascular disease. J Card Fail 11(3):206-12, 2005. PMID: 15812749.
103. Singh H, Gordon HS, Deswal A. Variation by race in factors contributing to heart failure hospitalizations. J Card Fail 11(1):23-9, 2005. PMID: 15704060.
104. Agoston I, Cameron CS, Yao D, Dela Rosa A, Mann DL, Deswal A. Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction. Am J Cardiol 94(8):1003-7, 2004. PMID: 15476612.
105. Deswal A, Petersen NJ, Souchek J, Ashton CM, Wray NP. Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol 43(5):778-84, 2004. PMID: 14998616.
106. Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 123(3):716-24, 2003. PMID: 12628868.
107. Moyé LA, Deswal A. Perils of the random experiment. Am J Ther 10(2):112-21, 2003. PMID: 12629589.
108. Wilson EM, Gunasinghe HR, Coker ML, Sprunger P, Lee-Jackson D, Bozkurt B, Deswal A, Mann DL, Spinale FG. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail 8(6):390-8, 2002. PMID: 12528092.
109. Moyé LA, Deswal A. The fragility of cardiovascular clinical trial results. J Card Fail 8(4):247-53, 2002. PMID: 12397573.
110. Misra A, Diwan A, Mann DL, Deswal A. Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure. Heart Fail Monit 3(2):42-8, 2002. PMID: 12634879.
111. Moyé LA, Deswal A. Trials within trials: confirmatory subgroup analyses in controlled clinical experiments. Control Clinical Trials 22(6):605-19, 2001. PMID: 11738119.
112. Deswal A, Petersen NJ, Feldman AM, White BG, Mann DL. Effects of Vesnarinone on Peripheral Circulating Levels of Cytokines and Cytokine Receptors in Patients with Heart Failure: a report from the Vesnarinone Trial. Chest 120(2):453-9, 2001. PMID: 11502643.
113. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103(16):2055-9, 2001. PMID: 11319194.
114. Kalra D, Bozkurt B, Deswal A, Torre-Amione G, Mann DL. Experimental options in the treatment of heart failure: the role of cytokine antagonism. Heart Fail Monit 1(4):114-21, 2001. PMID: 12634895.
115. Deswal A, Bozkurt B, Seta Y, Parilti-Eiswirth S, Hayes FA, Blosch C, Mann DL. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 99(25):3224-6, 1999. PMID: 10385494.
116. Gorcsan J, Deswal A, Mankad S, Mandarino WA, Mahler CM, Yamazaki N, Katz WE. Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient. Am J Cardiol 81(5):615-23, 1998. PMID: 9514460.
117. Bhadoria DP, Srivastava AK, Sharma M, Deswal A, Bhadoria P, Malhotra KK. Safe Use of Clonidine, Nifedipine and Vitamin K in Hepatic Porphyria. J Assoc Physicians India 36(11):675-6, 1988. PMID: 3248999.
118. Bhadoria DP, Srivastava AK, Sharma M, Deswal A, Malhotra KK. Ranitidine and Acute Intermittent Porphyria. J Assoc Physicians India 36(4):295-6, 1988. PMID: 3182690.
119. Walther CP, Winkelmayer WC, Deswal A, Niu J, Navaneethan SD. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol:1-10. e-Pub 2020. PMID: 31962311.

Invited Articles

1. Nair A, Deswal A. Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction. Heart Fail Clin 14(4):525-535, 2018. e-Pub 2018. PMID: 30266361.
2. Greet B, Schurmann P, Deswal A. In AF and HF, catheter ablation vs medical therapy reduced mortality and hospitalization for worsening HF. Ann Intern Med 168(10):JC55, 2018. PMID: 29800431.
3. Shah T, Kampangkaew J, Przybylowicz R, Deswal A. Ularitide in Acute Heart Failure. Curr Emerg Hosp Med Rep 6(17), 2018.
4. Mandviwala T, Khalid U, Deswal A. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?. Curr Atheroscler Rep 18(5):21, 2016. PMID: 26973130.
5. Khalid U, Deswal A. Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction. Evid. Based Med 18(6):226-7, 2013.
6. Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev 15(4):331-41, 2010. PMID: 19363700.
7. Deswal A, Bozkurt B. Treatment of patients with heart failure and preserved ejection fraction. Curr Treat Options Cardiovasc Med 10(6):516-28, 2008. PMID: 19026182.
8. Das A, Abraham S, Deswal A. Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol 23:233-40, 2008.
9. Ramasubbu K, Mann DL, Deswal A. Anti-angiotensin therapy: new perspectives. Cardiol Clin 25(4):573-80; vi-vii, 2007. PMID: 18063161.
10. Deswal A. Outcomes in Women vs. Men with Heart Failure and Preserved Ejection Fraction. Cardiology Review 24:24-27, 2007.
11. Deswal A. Review: B-type natriuretic peptide consistently predicts death and cardiovascular events in heart failure. ACP J Club 143(2):53, 2005. PMID: 16134927.
12. Deswal A. Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiology. Curr Cardiol Rep 7(3):178-83, 2005. PMID: 15865857.
13. Deswal A, Mann DL. Can Valsartan reduce the occurrence of atrial fibrillation in heart failure patients?. Nature Clin Pract Cardiovasc Med 2:502-503, 2005.
14. Kazi D, Deswal A. Role and Optimal Dosing of ACE Inhibitors in Heart Failure. Heart Failure Clinics 1:25-38, 2005.
15. Deswal, A. Commentary: B-type natriuretic peptide consistently predicts death and cardiovascular events in heart failure. BMJ 10:150, 2005.
16. Deswal A, Yao D. Aldosterone Receptor Blockers in the Treatment of Heart Failure. Curr Treat Options Cardiovasc Med 6(4):327-334, 2004. PMID: 15212727.
17. Mann DL, Deswal A, Bozkurt B, Torre-Amione G. New therapeutics for chronic heart failure. Annu Rev Med 53:59-74, 2002. PMID: 11818463.
18. Deswal A, Misra A, Bozkurt B. The role of anti-cytokine therapy in the failing heart. Heart Fail Rev 6(2):143-51, 2001. PMID: 11309533.
19. Bozkurt B, Deswal A, Mann DL. Left Ventricular Remodeling in the Failing Human Heart: Basic Mechanisms and Treatment. Cardiology Special Edition 6:11-13, 2000.
20. Torre-Amione G, Bozkurt B, Deswal A, Mann DL. An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol 14(3):206-10, 1999. PMID: 10358791.
21. Torre-Amione G, Bozkurt B, Deswal A, Mann DL. Tumor Necrosis Factor-a and the Failing Human Heart: An Overview. Curr Opin Cardiol 14:206-210, 1999.
22. Shan K, Kurrelmeyer K, Seta Y, Want F, Dibbs Z, Deswal A, Lee-Jackson D, Mann DL. The Role of Cytokines in Disease Progression in Heart Failure. Curr Opin Cardiol 12(3):218-23, 1997.

Manuals, Teaching Aids, Other Teaching Publications

1. Deswal A. Clinical Practice Guidelines/Recommendations: VHA Prosthetic Clinical Management Program (PCMP) Clinical Practice Recommendations on the Use of Left Ventricular Assist Devices (LVADs) for Destination Therapy for Patients with End Stage Heart Failure, 2004.

Other Articles

1. Arnett DK, Blumenthal RS, Albert MA, Michos ED, Buroker AB, Miedema MD, Goldberger ZD, Muñoz D, Hahn EJ, Smith SC Jr, Himmelfarb CD, Virani SS, Khera A, Williams KA Sr, Lloyd-Jones D, Yeboah J, McEvoy JW, Ziaeian B; ACC/AHA Task Force Members, O'Gara PT, Beckman JA, Levine GN, Chair IP, Al-Khatib SM, Hlatky MA, Birtcher KK, Ikonomidis J, Cigarroa JE, Joglar JA, Deswal A, Mauri L, Fleisher LA, Piano MR, Gentile F, Riegel B, Goldberger ZD, Wijeysundera DN 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol pii: S0735-1097(19)33877-X. doi: 10.1016/ j.jacc. 2019. 03.010, 2019.
2. Deswal A 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation. J Am Coll Cardiol 2019 Jan 21. pii: S0735-1097(19)30209-8. doi: 10.1016/j.jacc.2019.01.011, 2019.
3. Butler J, Anstrom KJ, Felker GM, et al. Efficacy and Safety of spironolactone in acute heart failure: The ATHENA-HF Randomzied Clinical Trial. JAMA Cardiol 2:950-958, 2017.
4. Margulies KB, Hernandez AF, Redfield MM, Givertz MM, Oliveira GH, Cole R, Mann DL, Whellan DJ, Kiernan MS, Felker GM, McNulty SE, Anstrom KJ, Shah MR, Braunwald E, Cappola TP NHLBI Heart Failure Clinical Research Network. JAMA. Effects of Liraglutide on Clinical Stability among Patients with Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. JAMA 316:500-508, 2016.
5. Khalid MU, Pokharel Y, Deswal A The obesity Paradox in heart Failure: Why does it matter clinically?. Expert Analysis on the ACC Cardiosource online, 2015.
6. Khalid U, Awar O, Verstovsek G, Cheong B, Yellapragada SV, Jneid H, Deswal A, Virani SS Case report: isolated cardiac amyloidosis: an enigma unravelled. Methodist DeBakey Cardiovasc J 11(1):53-8, 2015. PMID: 25793032.
7. Pitt B, Pfeffer MA, Assmann SF, et al. TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370(15):1383-92, 2014.
8. Deswal A, Bozkurt B Treatment of Heart Failure with Preserved Ejection Fraction. Curr Treat Optins Cardiovasc Med 10:516-28, 2008.
9. Ma TS, Mathuria NS, Hayes TG, Verstovsek G, Deswal A, Bredikis A Restoration of sinus rhythm by oral theophyline in a patient with octreotide-induced atriventricular block. Seminars in Cardiovasc. Med 14:1-4, 2008.
10. Dunlap ME, Beyth R, Deswal A, Massie B, Saleh J, et al Treating Chronic Heart Failure. VA Practice Matters 9:1-8, 2004.
11. Taylor AL, Ziesche S, Yancy C, et al. Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure. N Engl J Med 351:2049-2057, 2004.
12. Deswal A, Mann DL Commentary on Valsartan in Acute Myocardial Infarction Trial (VALIANT). Practical Medicine (Polish) 12(154):159-160, 2003.
13. Deswal A M.P.H. Thesis: Impact of Race on Health Care Utilization and Outcomes in Veterans with Congestive Heart Failure. University of Texas Health Science Center, School of Public Health, 2002.
14. Deswal A M.D. Thesis: Prevalence of Immunodeficiency in Connective Tissue Diseases. AIIMS, 1989.

Editorials

1. Khalid U, Jneid H, Deswal A. Higher risk, high yield: renin-angiotensin system blockade after percutaneous coronary intervention in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed) 73(2):104-106, 2020. PMID: 31575483.
2. Deswal A. Heart Failure With Reduced Ejection Fraction and Renal Dysfunction: Beta-Blockers Do Not Disappoint. J Am Coll Cardiol 74(23):2905-2907, 2019. PMID: 31806134.
3. Khalid U, Deswal A. Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction. Evid Based Med 18(6):226-7, 2013. PMID: 23585078.
4. Deswal A, Basra SS. Incident cancer in patients with heart failure: causation or mere association?. J Am Coll Cardiol 62(10):887-8, 2013. PMID: 23810872.
5. Mann DL, Deswal A. Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose. N Engl J Med 349(20):1963-5, 2003. PMID: 14610159.
6. Navaneethan SD, Yan J, Deswal A. Classification of Pulmonary Hypertension in CKD. Am J Kidney Dis. PMID: 32008859.

Abstracts

1. Kampangkaew J, Moran T, Nambi V, Deswal A, Misra A. Baseline right ventricular function is associated with reduced need of diuretics in patients with heart failure with improved ejection fraction. J Am Coll Card 73 (9 Supplement 1):786, 2019.
2. Cunningham LC, Fonarow G, Yancy C, Sheng S, Matsouaka RA, DeVore A, Jneid H, Deswal A. Regional Variations in Heart Failure Quality of Care and Outcomes. Circulation 138, Suppl_1, 2018.
3. Walther CP, Deswal A, Winkelmayer W, Morgan JA, Niu J, Cheema FH, Navaneethan S. Readmissions After Acute Kidney Injury (AKI) With Left Ventricular Assist Device (LVAD) Implantation: National Estimates. Circulation 138:A16406, 2018.
4. Stehlik J, Schmalfuss C, Bozkurt B, Nativi-Nicolau J, Wegerich S, Rose K, Ray R, Schofield R, Deswal A, Sekaric J, Anand S, Richards D, Hanson H, Pipke M, Pham M. Continuous wearable monitoring analytics predict heart failure decompensation: the LINK-HF multi-center study. J Am Coll Card 71 (11 Supplement):A646, 2018.
5. Nambi V, Sun W, Mcevoy J, De Lemos J, Hoogeveen R, Virani S, Aguilar D, Shah A, Ndumele C, Deswal A, Matsushita K, Selvin E, Folsom A, Ballantyne CM. NTproBNPand Incident Cardiovascular Events Across Systolic Blood Pressure Categories in the Atherosclerosis Risk in Communities (ARIC) Study. J Am Coll Cardiol 71 (11 Supplement):A1815, 2018.
6. Saeed A, Nambi V, Sun W, Virani S, Deswal A, Hoogeveen R, Wagenknecht , Taffet G, Matsushita K, Selvin E, Coresh J, De Lemos J, Ballantyne CM. Impact of Biomarkers on Short-Term Risk Prediction of Global Cardiovascular Events in Older Adults: Atherosclerosis Risk in Communities Study. J Am Coll Cardiol 71 (11 Supplement):A2668, 2018.
7. Saeed A, Nambi V, Sun W, Virani S, Deswal A, Hoogeveen R, Taffet G, Matsushita K, Selvin E, Coresh J, De Lemos J, Ballantyne CM. Levels of High Sensitivity Troponin T and Short Term Risk for Cardiovascular Events in Older Americans: Insights From the Atherosclerosis Risk in Communities Study. Circulation 136:A15162, 2017.
8. Griffin JM, Wruck LM, Silverman RK, Loehr LR, Russell SD, Matsushita K, Agarwal SK, Deswal A, Rosamond WD, Chang PP. Predictive Value of Changes in Serum Sodium in Patients with Acute Decompensated Heart Failure: The Atherosclerosis Risk in Communities Study. J Am Coll Cardiol 67(13):1421, 2016.
9. Cunningham L, Tanavin T, Alam M, Virani S, Bozkurt B, Deswal A, Nambi V, Jneid H. A multicenter study of the etiology and outcome of cardiac tamponade in the contemporary era. J Am Coll Cardiol 67 (13 Supplement):1466, 2016.
10. Owen B, Hoff J, Aguilar D, Denktas A, Virani S, Lakkis N, Bozkurt B, Deswal A, Shah T, Misra A, Jneid H, Ballantyne C, Nambi V. Publication Rates of Abstracts Presented at Major Cardiovascular Subspecialty Conferences. Circulation 134:A20656, 2016.
11. Basra SS, Wang T, Simon D, Chiswell K, Virani S, Alam M, Nambi V, Denktas A, Deswal A, Bozkurt B, Ballantyne CM, Peterson E, Jneid H. Aspirin dosing in patients with acute myocardial infarction treated with ticagrelor: insight from the national cardiovascular data registry (ncdr). J Am Coll Cardiol 67 (13 Supplement):537, 2016.
12. Bilen O, Marks S, Wruck L, Khalid U, Virani S, Nambi V , Jneid H, Cunningham L, Chang P, Bozkurt B , Deswal A. Heart Rate as a Prognostic Marker in Heart Failure with Preserved Ejection Fraction. Circulation 132:A16254, 2015.
13. Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele C, Solomon S, Bozkurt B, Selvin E, Ballantyne CM, Deswal A. Premorbid Body Mass Index, High sensitivity Troponin-T and mortality after incident heart failure hospitalization: The atherosclerosis risk in communities study (ARIC). J Am Coll Cardiol 65:A1003, 2015.
14. Francisco Y. Macedo, Chan W, Deswal A, Ramasubbu K, Civitello A, Bozkurt B. In patients with severe advanced heart failure, non-response to decrease LV filling pressure is not associated with worse survival and outcomes: insights from the escape (evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness) trial. J Am Coll Cardiol 65 (10 Supplement):A1018, 2015.
15. Deshpande A, Kar A, Paniagua D, Alam M, Deswal A, Jneid H. Tandem heart – percutaneuous left ventricular assist device treatment for severe refractory cardiogenic shock: the Debakey VA experience. J Am Coll Cardiol 63 (12 Supplement):A1854, 2014.
16. Ndumele CE, Matsushita K, Sang Y, Lazo M, Agarwal SK, Nambi V, Deswal A, Blumenthal RS, Ballantyne CM, Coresh J, Selvin E. NT-proBNP Predicts Incident Heart Failure Among Individuals in All BMI Categories. Circulation 129:AP0, 2014.
17. Gonçalves A, Jhund PS, Claggett B, Rosamond W, Deswal A, Aguilar D, Shah AM, Cheng S, Solomon SD. The Association between Alcohol Consumption and Risk of Heart Failure may be modified by Sex: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 129:AP026, 2014.
18. Sharma K, Agarwal SK, Matsushita K, Chang PP, Shah AM, Kitzman AM, Kitzman DW, Deswal A, Loehr LR, Coresh J, Rosamond WD, Solomon SD, Russell SD. Race and gender differences in survival among hospitalized heart failure with preserved ejection fraction: the ARIC study. Circulation 130:A9759, 2014.
19. Kumar A, Paniagua D, Kar B, Deswal A, Alam M, Omer S, Bakaeen F, Rosengart T, Blaustein A, Bozkurt B, Jneid. Safety and Effectiveness of Balloon Aortic Valvuloplasty for severe aortic stenosis in the contemporary era. J Am Coll Cardiol 63 (12_S), 2014.
20. Kumar A, Virani S, Bassett S, Alam M, Hira R, Caruso D, Paniagua D, Denktas A, Hamzeh I, Levine G, Ballantyne CM, Deswal A, Bozkurt B, Jneid. Persistent Thrombicyopneia after myocardial infarction is associated with increase short- and long-term mortality. Circulation 130:A19771, 2014.
21. Deshpande A, Kar B, Paniagua D, Alam M, Deswal A, Jneid H. Tandem Heart-Percutaneous Left Ventricular Assist Device Treatment for severe refractory cardiogenic shock: The DeBakey VA Experience. J Am Coll Cardiol 63 (12_S), 2014.
22. Hira RS, Kennedy K, Nambi V, Jneid H, Alam M, Basra SS, Ho PM, Deswal A, Ballantyne CM, Petersen LA, Virani SS. Frequency and Predictors of Inappropriate Aspirin Prescribing for Primary Prevention of Cardiovascular Disease: Insights from the NCDR® PINNACLE Registry. AHA Quality of Care and Outcomes Research Conference, 2014.
23. Virani SS, Maddox TM, Chan PS, Tang F, Akeroyd JM, Risch S, Deswal A, Bozkurt B, Ballantyne CM, Petersen LA. Provider Type and Quality of Outpatient Cardiovascular Disease Care, Implications for the Affordable Care Act: Insights from the NCDR®PINNACLE Registry. Circulation 130:A15347, 2014.
24. Khalid U, Wruck LM, Quibrera PM, Bozkurt B, Nambi V, Virani S, Basra S, Agarwal S, Chang PP, Loehr L, Rosamond W, Ballantyne CM, Deswal A. BNP as a Prognostic Marker in Obese Patients With Acute Heart Failure With Preserved vs. Reduced Ejection Fraction. Circulation 128:A16598, 2013.
25. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamond WB, Chang PP, Coresh J, Virani S, Nambi V, Bozkurt B, Ballantyne CM, Deswal A. Obesity Paradox in Heart Failure: Not all Cardiac Cachexia. Circulation 128:A15840, 2013.
26. Bavishi C, Ather S, Bozkurt B, Deswal A. Prognostic significance of hypoalbuminemia among ambulatory heart failure patients with reduced and preserved ejection fraction. Circulation 128:A16960, 2013.
27. Moez Aziz, Dinu Balanescu, Teodora Donisan, Juhee Song, Nicolas Palaskas, Juan Lopez-Mattei, Peter Kim, Mehmet Cilingiroglu, Joerg Herrmann, Konstantinos Marmagkiolis, Anita Deswal, Cezar Iliescu. Intracoronary Imaging-Guided Dual Antiplatelet Therapy Discontinuation in Cancer Patients with Cardiovascular Comorbidities. Division of Internal Medicine 2020 Retreat.
28. Moez Aziz, Teodora Donisan, Dinu Balanescu, Juhee Song, William Ntim, Nicolas Palaskas, Juan Lopez-Mattei, Peter Kim, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Anita Deswal, Cezar Iliescu. Cardiovascular Outcomes of Early Cancer Treatment Resumption After Percutaneous Coronary Intervention. Division of Internal Medicine 2020 Retreat.

Book Chapters

1. Fedson S, Misra A, Deswal A. Treatment of Heart Failure with Preserved Ejection Fraction. In: Heart Failure-a companion to Braunwald’s Heart Disease. 4. Saunders Elsevier: Philadelphia, 2019.
2. Cunningham L, Kayani W, Deswal A. Neurohormonal Blockade. In: The Encyclopedia of Cardiovascular Research and Medicine. Elsevier: Oxford, 459-476, 2018.
3. Kayani W, Deswal A. Neurohormonal Blockade. In: Color Atlas and Synopsis of Heart Failure. 1. McGraw Hill, 2018.
4. Khalid U, Deswal A. Heart Failure with Preserved Ejection Fraction. In: Cardiology Secrets. 5. Elsevier, Inc: Philadelphia, 2017.
5. Levine G, Deswal A, Blaustein A. Normal Valvular Anatomy and Function. In: Illustrated Guide to Cardiovascular Disease. Jaypee Medical Science Publishers: New Delhi, 2016.
6. Deswal A. Treatment of Heart Failure with Preserved Ejection Fraction. In: Heart Failure-a companion to Braunwald’s Heart Disease. 3. Saunders Elsevier: Philadelphia, 2016.
7. Editors- Question Writing Committee: Sean Pinney, Monica M. Colvin, Anita Deswal, Savitri Fedson, Michael Givertz, Lee Goldberg, Eldrin Lewis, Gurusher Panjrath, Flora Sam, Marc Semigran, Tina Shah, Frank Smart, MD, Nir Uriel. Online Advanced Heart Failure & Transplant Cardiology Self-Assessment Questions and Board Prep Program. In: American College of Cardiology, 2016.
8. Levine G, Deswal A, Blaustein A. Normal Valvular Anatomy and Function. In: Color Atlas of Cardiovascular Disease. Jaypee Medical Science Publishers: New Delhi, 2015.
9. Bozkurt B, Deswal A. Angiotensin Receptor Blockers. In: Clinical Decision Support: Cardiology a digital program on Cardiology, 2013.
10. Ather S, Deswal A. Heart Failure with Preserved Ejection Fraction. In: Cardiology Secrets. 4. Elsevier, Inc: Philadelphia, 2012.
11. Bozkurt B, Deswal A, Mann DL. Role of Inflammatory Biomarkers in Heart Failure. In: Cardiac Biomarkers in Modern Medicine: Practical Knowledge for the Clinician. Sudbury: MA, 2011.
12. Ramasubbu K, Deswal A. Medical Treatment of Systolic Heart Failure. In: Cardiology Board Review. McGraw Hill: New York, 2011.
13. Deswal A. Treatment of Heart Failure with Preserved Ejection Fraction. In: Heart Failure-a companion to Braunwald’s Heart Disease. Saunders Elsevier: Philadelphia, 2010.
14. Ramasubbu K, Deswal A. Emerging Strategies in the Treatment of Heart Failure. In: Heart Failure-a companion to Braunwald’s Heart Disease. Saunders Elsevier: Philadelphia, 2010.
15. Nguyen J, Deswal A. Heart Failure with Preserved Ejection Fraction: Diastolic Dysfunction. In: Cardiology Secrets. 3. Elsevier, Inc: Philadelphia, 2009.
16. Ramasubbu K, Deswal A. Treatment of Heart Failure: Inhibitors of the Renin Angiotensin Aldosterone System. In: Cardiology Secrets. 3. Elsevier, Inc: Philadelphia, 2009.
17. Deswal A, Mann DL. Angiotensin Receptor Blockers in Heart Failure. In: Cardiovascular Therapeutics. Blackwell Publishing Ltd: Oxford, 2006.
18. Kazi D, Deswal A. Role and optimal dosing of angiotensin-converting enzyme inhibitor therapy. In: Heart Fail Clin. 1, 25-37, 2005.
19. Deswal A, Barger P, Maclellan R, Mann D L. Emerging Strategies in the Treatment of Heart Failure. In: Heart Failure-a Companion to Braunwald’s Heart Disease. Saunders: Philadelphia, 2003.
20. Deswal A, Bozkurt B, Mann DL. The Clinical Experience with Anti-Cytokine Therapy in Heart Failure. In: Inflammation and Cardiac Diseases. Birkhauser Verlag: Basel, Switzerland, 2003.
21. Deswal A, Misra A, Bozkurt B. The Role of Anti-cytokine Therapy in the Failing Heart. In: The Role of Inflammatory Mediators in the Failing Heart. Kluwer Academic Publishers: Boston, 2001.
22. Deswal A, Follansbee WP. Cardiac Involvement in Scleroderma. In: Rheum Dis Clin North Am. 4, 841-60, 1996.
23. Deswal A. Sex Differences in Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension, in Sex-Differences in Pathophysiology, Presentation, Diagnosis and Management of Cardiac Disease. In: Sex Differences in Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension, in Sex-Differences in Pathophysiology, Presentation, Diagnosis and Management of Cardiac Disease. Elsevier.

Letters to the Editor

1. Borlaug BA, Chen H, Lin G, Redfield MM, Lewis GD, Semigran MJ, McNulty SE, LeWinter M, Deswal A, Margulies KB. Response to Letter Regarding Article, “Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction”. Circ Heart Fail 8(4):840, 2015.
2. Deswal A, Patel P. Beta-Blockers in systolic heart failure: Do physicians need more courage? Response to the Letter. Am Heart J 154:e25, 2007.